CMKLR1 and myeloid sarcoma: Given its ability to inhibit CMKLR1+ cell migration in vitro, we next asked if α-NETA could modulate immune pathology and inflammatory cell accumulation in the C57BL/6, MOG35-55-induced EAE model of MS.